Why it was recalled
CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.
Product description
Doxycycline Capsules, USP, 75 mg, 100-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-615-01.
Lot numbers, UPCs & expiration codes
Lot #: AA39490, Exp 03/2021
Where it was sold
Nationwide in the USA
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-1032-2020
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Mar 13, 2020
- FDA report date
- Mar 25, 2020
- Quantity
- 624 bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Sun Pharmaceutical Industries, Inc.
Original FDA data
Every field from FDA enforcement report D-1032-2020, exactly as published.
Show all FDA fields
- City
- Cranbury
- State
- NJ
- Status
- Terminated
- Country
- United States
- Event ID
- 85230
- Address
- 270 Prospect Plains Rd
- Code information
- Lot #: AA39490, Exp 03/2021
- Postal code
- 08512-3605
- Report date
- Mar 25, 2020
- Product type
- Drugs
- Recall number
- D-1032-2020
- Classification
- Class II
- Recalling firm
- Sun Pharmaceutical Industries, Inc.
- Product quantity
- 624 bottles
- Termination date
- Feb 9, 2021
- Reason for recall
- CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Doxycycline Capsules, USP, 75 mg, 100-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-615-01.
- Distribution pattern
- Nationwide in the USA
- Recall initiation date
- Mar 13, 2020
- Initial firm notification
- Letter
- Center classification date
- Mar 18, 2020